GSK GlaxoSmithKline PLC ADRs

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:GSK.

$38.62  +0.28 (0.73%)
As of 05/13/2021 12:06:01 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  09/04/2001
Outstanding shares:  2,515,538,097
Average volume:  5,064,297
Market cap:   $96,923,682,877
Current dividend yield:  5.39%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    37733W105
ISIN:        US37733W1053
Sedol:      2374112

---

Valuation   (See tab for details)

---

PE ratio:   13.11
PB ratio:   6.43
PS ratio:   2.12
Return on equity:   35.36%
Net income %:   16.21%